These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 38641203)

  • 1. Uveal melanoma: Current evidence on prognosis, treatment and potential developments.
    Gelmi MC; Jager MJ
    Asia Pac J Ophthalmol (Phila); 2024; 13(2):100060. PubMed ID: 38641203
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Uveal melanoma: A pathologist's perspective and review of translational developments.
    Schoenfield L
    Adv Anat Pathol; 2014 Mar; 21(2):138-43. PubMed ID: 24508696
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Liver metastasis in uveal melanoma - treatment options and clinical outcome.
    Kaštelan S; Mrazovac Zimak D; Ivanković M; Marković I; Gverović Antunica A
    Front Biosci (Landmark Ed); 2022 Feb; 27(2):72. PubMed ID: 35227015
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathology and genetics of uveal melanoma.
    Griewank KG; Murali R
    Pathology; 2013 Jan; 45(1):18-27. PubMed ID: 23222249
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Update on posterior uveal melanoma: treatment of the eye and emerging strategies in the prognosis and treatment of metastatic disease.
    Shildkrot Y; Wilson MW
    Curr Opin Ophthalmol; 2009 Nov; 20(6):504-10. PubMed ID: 19644367
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Delays between Uveal Melanoma Diagnosis and Treatment Increase the Risk of Metastatic Death.
    Stålhammar G
    Ophthalmology; 2024 Sep; 131(9):1094-1104. PubMed ID: 37995852
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [DEVELOPMENT AND CHALLENGES IN TREATMENT OF UVEAL MELANOMA].
    Zloto O; Vishnevskia-Dai V; Moisseiev J; Fabian ID
    Harefuah; 2018 Feb; 157(2):95-98. PubMed ID: 29484864
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic factors in uveal melanoma.
    Singh AD; Shields CL; Shields JA
    Melanoma Res; 2001 Jun; 11(3):255-63. PubMed ID: 11468514
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidemiology and management of uveal melanoma.
    Yonekawa Y; Kim IK
    Hematol Oncol Clin North Am; 2012 Dec; 26(6):1169-84. PubMed ID: 23116575
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New immunotherapy approaches as the most effective treatment for uveal melanoma.
    Eteghadi A; Ebrahimi M; Keshel SH
    Crit Rev Oncol Hematol; 2024 Feb; 194():104260. PubMed ID: 38199429
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current molecular and clinical insights into uveal melanoma (Review).
    Fallico M; Raciti G; Longo A; Reibaldi M; Bonfiglio V; Russo A; Caltabiano R; Gattuso G; Falzone L; Avitabile T
    Int J Oncol; 2021 Apr; 58(4):. PubMed ID: 33649778
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The pathological basis of the argument in the treatment of melanoma of the uveal tract].
    Li YP
    Zhonghua Yan Ke Za Zhi; 2012 Nov; 48(11):971-5. PubMed ID: 23302268
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evolving systemic targeted therapy strategies in uveal melanoma and implications for ophthalmic management: a review.
    Goh AY; Layton CJ
    Clin Exp Ophthalmol; 2016 Aug; 44(6):509-19. PubMed ID: 26601795
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Posterior uveal melanoma. The Swedish perspective.
    Seregard S
    Acta Ophthalmol Scand; 1996 Aug; 74(4):315-29. PubMed ID: 8883543
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical and histopathological features of choroidal melanoma-related enucleated eyes in a Spanish tertiary hospital.
    García Tirado A; Asencio Durán M; Berjón A; Ruiz Bravo-Burguillos E; Peralta Calvo J
    Arch Soc Esp Oftalmol (Engl Ed); 2019 May; 94(5):225-231. PubMed ID: 30904338
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tebentafusp in the treatment of metastatic uveal melanoma - the first patient treated in the Czech Republic.
    Klabusay M; Bábková B
    Klin Onkol; 2024; 38(2):134-138. PubMed ID: 38697822
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of circulating malignant cells and its correlation with prognostic factors and treatment in uveal melanoma. A prospective longitudinal study.
    Callejo SA; Antecka E; Blanco PL; Edelstein C; Burnier MN
    Eye (Lond); 2007 Jun; 21(6):752-9. PubMed ID: 16575415
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Uveal melanoma.
    Jager MJ; Shields CL; Cebulla CM; Abdel-Rahman MH; Grossniklaus HE; Stern MH; Carvajal RD; Belfort RN; Jia R; Shields JA; Damato BE
    Nat Rev Dis Primers; 2020 Apr; 6(1):24. PubMed ID: 32273508
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent approaches for the treatment of uveal melanoma: Opportunities and challenges.
    Khan SA; Almalki WH; Arora S; Kesharwani P
    Crit Rev Oncol Hematol; 2024 Jan; 193():104218. PubMed ID: 38040071
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent Advances in Molecular and Genetic Research on Uveal Melanoma.
    Fuentes-Rodriguez A; Mitchell A; Guérin SL; Landreville S
    Cells; 2024 Jun; 13(12):. PubMed ID: 38920653
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.